Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

583
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
583
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

636
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
636
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

342
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
342
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

754
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
754
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

627
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
627
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

746
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
746

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Roadmap to Revitalizing Academic Cardiovascular Medicine: A Perspective From the Association of Professors of Cardiology (APC) Emerging Leaders Group.

Journal of the American College of Cardiology·2026
Same author

Short-term repeatability of artificial intelligence estimated electrocardiographic age.

Journal of electrocardiology·2025
Same author

MYL4 Identifies Intramural Anatomy of Purkinje Fibers in Human Hearts.

JACC. Clinical electrophysiology·2025
Same author

Characteristics of Patients With the Arrhythmogenic Mitral Valve Prolapse Syndrome and Sudden Cardiac Arrest and Sustained Ventricular Arrhythmias.

Circulation. Arrhythmia and electrophysiology·2025
Same author

Left ventricular hypertrophy and ventricular ectopy in mitral valve prolapse.

International journal of cardiology·2024
Same author

Advancing Cardiovascular Risk Assessment with Artificial Intelligence: Opportunities and Implications in North Carolina.

North Carolina medical journal·2024

Related Experiment Video

Updated: Apr 26, 2026

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
07:20

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

2.7K

Constrictive pericarditis--a curable diastolic heart failure.

Faisal F Syed1, Hartzell V Schaff2, Jae K Oh1

  • 1Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Nature Reviews. Cardiology
|July 30, 2014
PubMed
Summary

Constrictive pericarditis, a stiff pericardium hindering heart filling, requires accurate diagnosis to differentiate from other heart failures. Early identification is key for effective treatment, potentially including surgery or anti-inflammatory therapy.

More Related Videos

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

2.5K
An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

2.2K

Related Experiment Videos

Last Updated: Apr 26, 2026

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
07:20

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

2.7K
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

2.5K
An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

2.2K

Area of Science:

  • Cardiology
  • Medical Diagnostics

Background:

  • Constrictive pericarditis impedes diastolic filling due to pericardial stiffness.
  • Distinguishing it from restrictive cardiomyopathy is crucial for treatment selection.

Purpose of the Study:

  • To review the etiology, pathophysiology, and diagnosis of constrictive pericarditis.
  • To emphasize differentiating constrictive pericarditis from similar conditions.

Main Methods:

  • Echocardiography
  • Cardiac catheterization
  • Cardiac MRI
  • CT scans

Main Results:

  • Diagnostic criteria rely on hemodynamic and anatomical features.
  • Ventricular interdependence and pressure dissociation are key indicators.
  • Pericardiectomy can cure, while anti-inflammatory therapy may treat transient forms.

Conclusions:

  • Early diagnosis of constrictive pericarditis is clinically vital.
  • Understanding its development is critical for preventing diastolic heart failure.
  • Accurate differentiation from other heart failure causes guides treatment.